Pages that link to "Q41814694"

The following pages link to Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilization (Q41814694):

Displaying 37 items.

• High FSH:LH ratio and low LH levels in basal cycle day 3: impact on follicular development and IVF outcome (Q28362311) (← links)
• Laboratory markers of ovarian function. (Q34065653) (← links)
• Human intraovarian interleukin-1 (IL-1) system: highly compartmentalized and hormonally dependent regulation of the genes encoding IL-1, its receptor, and its receptor antagonist (Q34219571) (← links)
• Predicting pregnancy in women undergoing in-vitro fertilization with basal serum follicle stimulating hormone levels between 10.0 and 11.9 IU/L (Q35173114) (← links)
• Cumulative exposure to high estradiol levels during the follicular phase of IVF cycles negatively affects implantation (Q36268880) (← links)
• Single and repeated GnRH agonist stimulation tests compared with basal markers of ovarian reserve in the prediction of outcome in IVF. (Q36270584) (← links)
• The antral follicle count predicts the outcome of pregnancy in a controlled ovarian hyperstimulation/intrauterine insemination program (Q36308433) (← links)
• Dynamic tests of ovarian reserve: a systematic review of diagnostic accuracy (Q37528691) (← links)
• Prognostic assessment of ovarian reserve. (Q40559964) (← links)
• Day 4 Estradiol Levels Predict Pregnancy Success in Women Undergoing Controlled Ovarian Hyperstimulation for IVF (Q40855336) (← links)
• The initial flare-up induced by gonadotropin releasing hormone agonist may serve as a predictor of ovarian response in the current IVF-ET treatment cycle in normogonadotropic women aged 40-48 years (Q40940726) (← links)
• Estrogen biosynthesis--regulation, action, remote effects, and value of monitoring in ovarian stimulation cycles. (Q41001302) (← links)
• Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve (Q43872544) (← links)
• Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging (Q44077004) (← links)
• Clinical outcome of using ganirelix acetate versus a 4-day follicular phase leuprolide acetate protocol in unselected women undergoing in vitro fertilization (Q44505656) (← links)
• Fine tuning cycle day 3 hormonal assessment of ovarian reserve improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles (Q44648854) (← links)
• The gonadotropin-releasing hormone agonist stimulation test--a sensitive predictor of performance in the flare-up in vitro fertilization cycle. (Q44944606) (← links)
• Preferred protocol: controlled ovarian stimulation (Q45088168) (← links)
• Simultaneous evaluation of basal follicle-stimulating hormone and 17 beta-estradiol response to gonadotropin-releasing hormone analogue stimulation: an improved predictor of ovarian reserve (Q47719508) (← links)
• Early pituitary desensitization and ovarian suppression with leuprolide acetate is associated with in vitro fertilization-embryo transfer success. (Q48660511) (← links)
• Ovarian reserve tests in infertility practice and normal fertile women (Q48925934) (← links)
• Comparison of synthetic serum substitute and fetal cord serum as media supplements for in vitro fertilization: a prospective, randomized study (Q48968925) (← links)
• The duration of leuprolide acetate administration prior to ovulation induction does not impact ovarian responsiveness to exogenous gonadotropins. (Q49137506) (← links)
• The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization (Q50793579) (← links)
• Basal follicle-stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilization (Q63359251) (← links)
• The Lupron screening test: tailoring the use of leuprolide acetate in ovarian stimulation for in vitro fertilization (Q67991929) (← links)
• Gonadotropin responsiveness to ultralow-dose leuprolide acetate administration in baboons (Q70693851) (← links)
• Ovarian activity during follicular-phase down regulation in in vitro fertilization is associated with advanced maternal age and a high recurrence rate in subsequent cycles (Q70783944) (← links)
• High continuing pregnancy rates after in vitro fertilization-embryo transfer using medium supplemented with a plasma protein fraction containing alpha- and beta-globulins (Q71617427) (← links)
• Prognostic value of day 3 estradiol on in vitro fertilization outcome (Q71816464) (← links)
• "Poor responders": screening and treatment possibilities (Q72851260) (← links)
• The poor-responder patient in an in vitro fertilization-embryo transfer program (Q72851262) (← links)
• The significance of elevated FSH for reproductive function (Q72897076) (← links)
• Follicle-stimulating hormone levels on cycle day 3 to predict ovarian response in women undergoing controlled ovarian hyperstimulation for in vitro fertilization using a flare-up protocol (Q73742791) (← links)
• Premature Luteinization: Could It Be An Early Manifestation of Low Ovarian Reserve? (Q74413768) (← links)
• Follicle stimulating hormone as a predictor of fertility (Q74627375) (← links)
• The detection of diminished ovarian reserve in infertile women (Q77362720) (← links)